All life is important, and that is what the esteemed Securus Technologies does by making life worth living even to the inmates. Securus Technology has been long serving prison and correctional facilities with communication technology services. This help inmates communicate with their family, lawyers, friends, and also within the convicted perimeter walls.
Richard A. Smith, the Chairman, and CEO of the Securus Technologies recently reported that they could frequently do new product development for efficiency and effectiveness of the correctional procedures. This has been aided by the feedback received in the form of letters and emails that have helped identify their areas of strength and those that require improvement. This continuous evaluation has made Securus Technologies be ranked among the largest companies in curbing crime through technology.
Some of the feedback and reviews of the company’s functionality have been positive. They have established a proportional relationship with the facility’s ability to provide public safety, monitor flow of things, and allow for investigation and correction of inmates. Sample customer comments tell of the good of this technology. For instance, the controlled and recorded calls have helped arrest associate wrong doers, track down societal ills such as drug trafficking and abuse, fraudulent money laundering, illegally acquired assets, perpetrators of crime among others.
Their database can give leads through which the investigative tool can follow. Just recently, some corrupt jail and prison official has had to face the full force of the law for either collaborating with inmates or unethical practices. Networking with legal advisors has helped some inmates be relieved of a sentence. More positively, inmates can go through sessions of corrections monitored by the system.
About Securus Technologies
Secures technologies was established in 1986 by Richard Falcone but presently headed by CEO Richard Smith since 2008. It has partnered with Harris Corporation for technological advancement. Apparently, it has effective systems such as Managed Access Solutions, GPS Tracking, Cell Defender Technology and the up to date Wireless Containment Solutions.
Entrepreneur and Business man Todd Lubar has been making an impact on the business world for quite some time. Lubar has spent more than two decades working in the real estate and business world. Lubar has built a reputation as a great leader who is willing to work with people from all walks of life. He has a firm philosophy on what it takes to be a great leader. This philosophy is a large factor in the success he has had.
A graduate of Syracuse University, Todd Lubar is the President and Sr. VP to Legendary Investments at TDL GLOBAL VENTURES, LLC. Lubar earned a degree in speech and soon after college began working his first job with Crestar Mortgage Corporation. Lubar’s began to earn lots of experience in the real estate field. Some of his other positions included with Crestar and Legacy Financial group in 1999. Lubar’s work at Legacy was quite impressive. He helped lead the Maryland based group to more than 100 million dollars in loan volume. Todd Lubar worked with Legacy for more than seven years before moving to his next job as Senior Vice President with Charter Funding. Check out Medium to know more.
According to Patch, Lubar’s talents extend far beyond the world of real estate. Todd Lubar owns several companies including companies in the demolition business, the recycling industry, night clubs and real estate development. Lubar’s work in the real estate world has been recognized by many. He has been listed among the top 25 mortgage originators in the country on several different occasions. Lubar has become known for his passion for helping people reach their home owning dreams. Lubar is committed to helping memebers of the community in any way that he can. With an impressive track record and a passion for helping others, Todd Lubar appears destined for success in the business world for many more years to come.
The civil litigators are a multi-tasker and starting from when he or she picks up the case. Litigators not only have to take care of the legal proceedings, but attorney also needs to do a considerable amount of investigative work as well. It can include collecting medical records, statements from the witness, receiving documents from all the concerned authorities and organizations, and more. Gathering evidence is an important part of the litigation process as it helps in strengthening the case.
When there is sufficient evidence available to make the case sufficiently high, a civil litigator will reach out to the other party to ask for an out of the court settlement. It is a widely known fact that many of the legal cases are closed through the out of the court settlement and is a widely used practice. It helps in saving time as well as considerable amount of money as the court proceedings may take months or even years to reach a decision, and the legal expenses can build up fast over time. In many cases when the settlement is not reached, the discovery phase is resumed next, and the case goes to trial.
Karl Heideck is one of the most noted civil attorneys from the Greater Philadelphia region, and over the years has successfully fought numerous cases for his clients that range from individuals to large scale organizations. Karl Heideck is considered an authority on the niche of compliance law and mergers and acquisitions. The authority of Karl Heideck on compliance law is unchallenged in Philadelphia. Karl Heideck suggests and outlines a operational model for his clients to stay compliant as per the government’s guidelines. It ensures that his clients does not attract any penalties and continues to operate within the framework suggested by the government. Karl Heideck has done graduation from Swarthmore College and studied law at James Beasley School of Law.
One major challenge facing the modern world is the high mortality rate caused by diseases. These diseases are mostly chronic illnesses which haven’t had any or significant treatment breakthrough over the decades. This has led medical practitioners to come up with institutions that deal with the development of targeted therapy drug for such diseases. One of the most notable medical practitioners in this area is Dr. Clay Siegall. He is the founder and CEO of a biotech firm based in Seattle, dabbed as Seattle Genetics.
About Seattle Genetics
The firm focuses more on finding significant breakthroughs in medicine. Its way of achieving this, is by continually developing targeted therapy drugs for such diseases. Seattle Genetics was founded in the year 1998, and since then, Dr. Clay Siegall has steered the firm to a remarkable height. The firm developed the first FDA-approved antibody drug conjugate that has over the time received substantial approvals. The firm has strategically partnered with various drug manufacturers such as; Genentech, Pfizer, Bayer among others, in providing a wide range of variety of drugs that have proven to be remarkable. Under his leadership, the firm has seen great improvement in growth. During its early years in the industry the company had very few and not well known researchers. This soon changed over the years and currently it’s among the top players in the Research on Cancer.
Dr. Siegall does not plan to stop there yet, this is because the list of drugs in the development pipeline is still growing and need reliable firms such Seattle Genetics for a breakthrough. The struggle in offering effective treatment against these diseases still prove to be challenging but firms such as Seattle are still keeping up the fight. Dr. Clay Siegall will not stop nor give up on ensuring that we all have a healthier world.
Personal Details on Dr. Siegall
Dr. Siegall has involved himself in capital raising, whereby he managed to secure $675 million through public and private donors who were in support for his work. Early in his life, he previously worked with National Institutes of Health, for a period ranging from 1988 to 1991. He later joined a research institute, where he worked from 1991 to 1997, known as Bristol-myers Squibb Pharmaceutical Research Institute. His reputation and knowledge in his area of expertise allowed him to serve on the board of directors of a private biotechnology company Alder Biopharmaceuticals. In addition, Dr Siegall is an author and holds more than 70 publications and 15 patents under his name. He received his Ph.D. in Genetics from George Washington University and a B.S. in Zoology from the University of Maryland. He surely is a force to reckon with in this industry.